The EBMT activity survey on hematopoietic-cell transplantation and cellular therapy 2018: CAR-T’s come into focus
Author
Passweg, Jakob R.; Baldomero, Helen; Chabannon, Christian; Basak, Grzegorz W.; Corbacioglu, Selim; Duarte Palomino, Rafael; Dolstra, Harry; Lankester, Arjan C.; Mohty, Mohamad; Montoto, Silvia; Peffault de Latour, Régis; Snowden, John A.; Styczynski, Jan; Yakoub-Agha, Ibrahim; Kröger, NicolausEntity
UAM. Departamento de MedicinaPublisher
Springer NatureDate
2020-02-17Citation
10.1038/s41409-020-0826-4
Bone Marrow Transplantation 55.8 (2020): 1604-1613
ISSN
0268-3369 (print); 1476-5365 (online)DOI
10.1038/s41409-020-0826-4Editor's Version
https://doi.org/10.1038/s41409-020-0826-4Subjects
Hematopoietic-cell transplantation (HCT); Lymphoid malignancies; Cellular therapies; European Society for Blood and Marrow Transplantation (EBMT); MedicinaRights
© 2020 The AuthorsAbstract
Hematopoietic-cell transplantation (HCT) is widely used for acquired and congenital disorders of the hematopoietic system. Number of transplants performed in Europe and associated countries continues to rise with 47,468 HCT in 42,901 patients [19,630 allogeneic (41%) and 27,838 autologous (59%)] reported by 701 centers in 50 countries in 2018. Main indications were myeloid malignancies 10,679 (25%; 97% allogeneic), lymphoid malignancies 27,318 (64%; 20% allogeneic), solid tumors 1625 (4%; 2.9% allogeneic), and nonmalignant disorders 3063 (7%; 81% allogeneic). This year’s analysis focuses on cellular therapies with the marked growth in CAR T-cell therapies from 151 in 2017 to 301 patients reported in 2018. Other cellular therapy numbers show less significant changes. Important trends in HCT include a 49% increase in allogeneic HCT for chronic phase CML (although transplant numbers remain low) and a 24% increase in aplastic anemia. In autologous HCT, there is an ongoing increase in autoimmune diseases (by 19%), predominantly due to activity in multiple sclerosis. This annual report reflects current activity and highlights important trends, useful for health care planning.
Files in this item
Google Scholar:Passweg, Jakob R.
-
Baldomero, Helen
-
Chabannon, Christian
-
Basak, Grzegorz W.
-
Corbacioglu, Selim
-
Duarte Palomino, Rafael
-
Dolstra, Harry
-
Lankester, Arjan C.
-
Mohty, Mohamad
-
Montoto, Silvia
-
Peffault de Latour, Régis
-
Snowden, John A.
-
Styczynski, Jan
-
Yakoub-Agha, Ibrahim
-
Kröger, Nicolaus
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE)
Snowden, John A.; Saccardi, Riccardo; Orchard, Kim; Ljungman, Per; Duarte Palomino, Rafael; Labopin, Myriam; McGrath, Eoin; Brook, Nigel; de Elvira, Carmen Ruiz; Gordon, Debra; Poirel, Hélène A.; Ayuk, Francis; Beguin, Yves; Bonifazi, Francesca; Gratwohl, Alois; Milpied, Noel; Moore, John; Passweg, Jakob; Rizzo, J. Douglas; Spellman, Stephen R.; Sierra, Jorge; Solano, Carlos; Sanchez-Guijo, Fermin; Worel, Nina; Gusi, Andreu; Adams, Gillian; Balan, Theodor; Baldomero, Helen; Macq, Gilles; Marry, Evelyne; Mesnil, Florence; Oldani, Elena; Pearce, Rachel; Perry, Julia; Raus, Nicole; Schanz, Urs; Tran, Steven; Wilcox, Leonie; Basak, Grzegorz W.; Chabannon, Christian; Corbacioglu, Selim; Dolstra, Harry; Kuball, Jürgen; Mohty, Mohamad; Lankester, Arjan; Montoto, Sylvia; Nagler, Arnon; Styczynski, Jan; Yakoub-Agha, Ibrahim; de Latour, Regis Peffault; Kroeger, Nicolaus; Brand, Ronald; de Wreede, Liesbeth C.; van Zwet, Erik; Putter, Hein
2019-10-21 -
Correction: Benchmarking of survival outcomes following haematopoietic stem cell transplantation: A review of existing processes and the introduction of an international system from the European Society for Blood and Marrow Transplantation (EBMT) and the Joint Accreditation Committee of ISCT and EBMT (JACIE) (Bone Marrow Transplantation, (2020), 55, 4, (681-694), 10.1038/s41409-019-0718-7)
Snowden, John A.; Saccardi, Riccardo; Orchard, Kim; Ljungman, Per; Duarte Palomino, Rafael; Labopin, Myriam; McGrath, Eoin; Brook, Nigel; de Elvira, Carmen Ruiz; Gordon, Debra; Poirel, Hélène A.; Ayuk, Francis; Beguin, Yves; Bonifazi, Francesca; Gratwohl, Alois; Milpied, Noel; Moore, John; Passweg, Jakob; Rizzo, J. Douglas; Spellman, Stephen R.; Sierra, Jorge; Solano, Carlos; Sanchez-Guijo, Fermin; Worel, Nina; Gusi, Andreu; Adams, Gillian; Balan, Theodor; Baldomero, Helen; Macq, Gilles; Marry, Evelyne; Mesnil, Florence; Oldani, Elena; Pearce, Rachel; Perry, Julia; Raus, Nicole; Schanz, Urs; Tran, Steven; Wilcox, Leonie; Basak, Grzegorz W.; Chabannon, Christian; Corbacioglu, Selim; Dolstra, Harry; Kuball, Jürgen; Mohty, Mohamad; Lankester, Arjan; Montoto, Sylvia; Nagler, Arnon; Styczynski, Jan; Yakoub-Agha, Ibrahim; de Latour, Regis Peffault; Kroeger, Nicolaus; Brand, Ronald; de Wreede, Liesbeth C.; van Zwet, Erik; Putter, Hein
2020-04-01 -
The EBMT activity survey report 2017: A focus on allogeneic HCT for nonmalignant indications and on the use of non-HCT cell therapies
Passweg, Jakob R.; Baldomero, Helen; Basak, Grzegorz W.; Chabannon, Christian; Corbacioglu, Selim; Duarte Palomino, Rafael; Kuball, Jürgen; Lankester, Arjan; Montoto, Silvia; Peffault de Latour, Régis; Snowden, John A.; Styczynski, Jan; Yakoub-Agha, Ibrahim; Arat, Mutlu; Mohty, Mohamad; Kröger, Nicolaus
2019-02-06